Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Gimme Care vs Spry

Two GLP-1 deals, scored on the same six factors. Gimme Care lands a Value Score of 91, Spry a 65. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Gimme Care

#5 · Grade A · Best Value

Est. first month

$130/mo

Save ~90% vs brand-name
Get this deal Full Gimme Care review →
VS

Spry

#318 · Grade C · Watch List

Est. first month

From $199/mo (starting dose, compounded)

Save ~85% vs brand-name
Get this deal Full Spry review →

The verdict

Better value: Gimme Care

Gimme Care takes it on Value Score, 91 to 65 an est. $130/mo first month, with no teaser step-up baked in. Spry isn't out of it: Shoppers who want compounded GLP-1 plus anti-aging peptides under one membership.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealGimme CareSpry
Value Score91 (A)65 (C)
Est. first month$130/moFrom $199/mo (starting dose, compounded)
Save vs brand-name~90%~85%
Semaglutide$130/moFrom $199/mo (starting dose, compounded)
Tirzepatide$163/moFrom $299/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

93
Lowest Real Price
72
Gimme Care: 93. Spry: 72.
88
No Teaser-Rate Bait
64
Gimme Care: 88. Spry: 64.
98
Nationwide Availability
45
Gimme Care: 98. Spry: 45.
92
Both Molecules
92
Gimme Care: 92. Spry: 92.
84
Easy Cancellation
58
Gimme Care: 84. Spry: 58.
82
Reputation
31
Gimme Care: 82. Spry: 31.

Gimme Care

Genuinely cheap on both molecules ($130 / $163) with a LegitScript-certified pharmacy and all-50-state reach.

Why it's a deal

  • Low flat price on both molecules ($130 sema / $163 tirz)
  • LegitScript-certified pharmacy
  • Available in all 50 states

The fine print

  • No brand-name option — compounded only
  • No oral/sublingual form

Spry

Spry is a weight-loss and anti-aging telehealth platform pairing compounded semaglutide ($199/mo) and tirzepatide ($299/mo) with three longevity peptides — BPC-157, NAD+, and sermorelin ($249–$299/mo).

Why it's a deal

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

The fine print

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Get the Gimme Care deal Get the Spry deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Gimme Care is ranked on the Gimme Care alternatives board, and the same list for the other side is on alternatives to Spry.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.